Future clinical development should focus on biomarker-guided patient selection and the development of formulations that ensure consistent bioavailability to maximize therapeutic efficacy
if the image is not included under the Creative Commons license, users will need to obtain permission from the license holder in order to reproduce the image
Do not blow on it, do not wipe it, do not rush it
One promising therapy for improving cardiac health involves using L-carnitine to improve free fatty acid levels and glucose oxidation. The potential mechanisms responsible for the observed beneficial impact of L-carnitine in acute myocardial infarction are likely multifactorial and may, in part, be conferred through the ability of L-carnitine to improve mitochondrial energy metabolism in the heart by facilitating the transport of long-chain fatty acids from the cytosol to the mitochondrial matrix, where b-oxidation occurs, removing toxic fatty acid intermediates, reducing ischemia induced by long-chain fatty acid concentrations, and replenishing depleted carnitine concentrations seen in ischemic, infarcted, and failing myocardium, says DiNicolantonio
Upon activation, microglia upregulate NADPH oxidase 2 which produces superoxide and inducible nitric oxide synthase, ultimately generating nitric oxide